Lineage, Inc. Common Stock (LINE)vsSmith Douglas Homes Corp. (SDHC)
LINE
Lineage, Inc. Common Stock
$37.75
+0.96%
REAL ESTATE · Cap: $9.50B
SDHC
Smith Douglas Homes Corp.
$10.58
+1.54%
REAL ESTATE · Cap: $94.08M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 436% more annual revenue ($5.37B vs $1.00B). SDHC leads profitability with a 0.6% profit margin vs -3.1%. SDHC earns a higher WallStSmart Score of 46/100 (D+).
LINE
Avoid35
out of 100
Grade: F
SDHC
Hold46
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
-46.1%
Fair Value
$12.34
Current Price
$10.58
$1.76 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Attractively priced relative to earnings
Revenue surging 21.9% year-over-year
Areas to Watch
0.8% revenue growth
0.0% earnings growth
Operating margin of 3.7%
Elevated debt levels
Smaller company, higher risk/reward
0.6% margin — thin
Operating margin of 2.2%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : SDHC
The strongest argument for SDHC centers on Price/Book, Altman Z-Score, P/E Ratio. Revenue growth of 21.9% demonstrates continued momentum.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : SDHC
The primary concerns for SDHC are Market Cap, Profit Margin, Operating Margin. Thin 0.6% margins leave little buffer for downturns.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while SDHC is a growth play — different risk/reward profiles.
LINE carries more volatility with a beta of 0.88 — expect wider price swings.
SDHC is growing revenue faster at 21.9% — sustainability is the question.
LINE generates stronger free cash flow (186M), providing more financial flexibility.
Bottom Line
SDHC scores higher overall (46/100 vs 35/100) and 21.9% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Smith Douglas Homes Corp.
REAL ESTATE · REAL ESTATE - DEVELOPMENT · USA
Smith Douglas Homes Corp. The company is headquartered in Woodstock, Georgia.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?